Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingqiao Xiaodu Granules is a Traditional Chinese Medicine (TCM) formulation primarily used for its heat-clearing and detoxifying properties. It is indicated for the treatment of upper respiratory tract infections, acute pharyngitis, and tonsillitis, specifically targeting symptoms such as fever, sore throat, and cough. The preparation typically contains a combination of herbal extracts, including *Scutellaria baicalensis* (Baical Skullcap Root) and *Forsythia suspensa* (Weeping Forsythia Capsule), which provide anti-inflammatory, antibacterial, and antiviral activities. It is widely used in China as an over-the-counter or prescription remedy for early-stage viral and bacterial infections of the throat and respiratory system.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingqiao Xiaodu Granules.